Qube Research & Technologies (QRT)
IMGN

Qube Research & Technologies (QRT)’s Immunogen Inc IMGN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-263,880
Closed -$7.82M – 5011
2023
Q4 		$7.82M Buy
+263,880
New +$5.25M 0.02% 836
2023
Q2 		– Sell
-42,516
Closed -$163K – 3170
2023
Q1 		$163K Buy
+42,516
New +$181K ﹤0.01% 1994
2022
Q4 		– Sell
-335,370
Closed -$1.6M – 3132
2022
Q3 		$1.6M Buy
335,370
+323,133
+2,641% +$1.7M 0.01% 1026
2022
Q2 		$55K Buy
+12,237
New +$53.2K ﹤0.01% 2102
2021
Q4 		– Sell
-10,476
Closed -$59K – 3085
2021
Q3 		$59K Sell
10,476
-42,752
-80% -$247K ﹤0.01% 1861
2021
Q2 		$351K Sell
53,228
-21,360
-29% -$149K ﹤0.01% 1481
2021
Q1 		$604K Buy
74,588
+51,777
+227% +$423K 0.01% 1070
2020
Q4 		$147K Buy
+22,811
New +$133K ﹤0.01% 1589
2020
Q3 		– Sell
-90,783
Closed -$418K – 2198
2020
Q2 		$418K Buy
+90,783
New +$386K 0.01% 1188

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IMGN Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 263,880 shares — an estimated $7.82M sold.

Qube Research & Technologies (QRT) first reported a position in IMGN in Q2 2020 and held it in 9 quarters. The position peaked at $7.82M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 263,880 Immunogen Inc shares in Q1 2024, an estimated $7.82M.
  • Qube Research & Technologies (QRT) first reported a position in Immunogen Inc in Q2 2020 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s Immunogen Inc position peaked at $7.82M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.